Functionalization of electrospun poly(ε-caprolactone) scaffold with heparin and vascular endothelial growth factors for potential application as vascular grafts

Journal of Bioactive and Compatible Polymers

Volumn 28, Issue 2, 2013, Pages 154-166

  Wang, Zhexiang ^a   Sun, Bin ^a   Zhang, Min ^a   Ou, Lailiang ^a   Che, Yongzhe ^a   Zhang, Jun ^a   Kong, Deling ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

functional scaffold; heparin; Poly( caprolactone); vascular endothelial growth factor; vascular grafts

Indexed keywords

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ANTICOAGULATION PROPERTIES; CAPROLACTONE; HEPARIN; SMALL-DIAMETER VASCULAR GRAFTS; VASCULAR ENDOTHELIAL GROWTH; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR GRAFTS;

BIOCOMPATIBILITY; CELL ADHESION; ELECTROSPINNING; ENDOTHELIAL CELLS; GRAFTS; POLYSACCHARIDES;

SCAFFOLDS;

HEPARIN; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULATION; ARTERIOVENOUS SHUNT; ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; BLOOD VESSEL GRAFT; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROSPINNING; HUMAN; HUMAN CELL; MALE; NONHUMAN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN IMMOBILIZATION; RAT; SUSTAINED DRUG RELEASE; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM;

EID: 84875843961     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911512469707     Document Type: Article

References (49)

1. Schmedlen RH, Elbjeirami WM, Gobin AS, et al. Tissue engineered small-diameter vascular grafts. Clin Plast Surg. 2003 ; 30 (4). 507-517 (Pubitemid 37351923)
2. Yao C, Roderfeld M, Rath T, et al. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials. 2006 ; 27 (8). 1608-1616 (Pubitemid 41739586)
3. Woodward SC, Brewer PS, Moatamed F, et al. The intracellular degradation of poly(epsilon-caprolactone). J Biomed Mater Res. 1985 ; 19 (4). 437-444
4. Griffith LG, Naughton G. Tissue engineering - current challenges and expanding opportunities. Science. 2002 ; 295 (5557). 1009-1014
5. Zilla P, Fasol R, Preiss P, et al. Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts. Surgery. 1989 ; 105 (4). 515-522 (Pubitemid 19105061)
6. Nie H, Soh BW, Fu YC, et al. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng. 2008 ; 99 (1). 223-234
7. Cai S, Liu Y, Zheng SX, et al. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials. 2005 ; 26 (30). 6054-6067 (Pubitemid 40805611)
8. Chua CC, Rahimi N, Forsten-Williams K, et al. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res. 2004 ; 94 (3). 316-323 (Pubitemid 38240722)
9. DiGabriele AD, Lax I, Chen DI, et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature. 1998 ; 393 (6687). 812-817 (Pubitemid 28299496)
10. Ping W, Ping G, Yi L, et al. Nanofibrous electrospun barrier membrane promotes osteogenic differentiation of human mesenchymal stem cells. J Bioact Compat Polym. 2011 ; 26 (6). 607-618
11. Hualin Z. Effects of electrospinning parameters on morphology and diameter of electrospun PLGA/MWNTs fibers and cytocompatibility in vitro. J Bioact Compat Polym. 2011 ; 26 (6). 590-606
12. Spasova M, Manolova N, Naydenov M, et al. Electrospun biohybrid materials for plant biocontrol containing chitosan and Trichoderma viride spores. J Bioact Compat Polym. 2011 ; 26 (1). 48-55
13. Bianco A, Marida B, Cacciotti B, et al. Poly(l-lactic acid)/calcium-deficient nanohydroxyapatite electrospun mats for bone marrow stem cell cultures. J Bioact Compat Polym. 2011 ; 26 (3). 225-241
14. Hualin Z. Electrospun poly(lactic-co-glycolic acid)/multiwalled carbon nanotubes composite scaffolds for guided bone tissue regeneration. J Bioact Compat Polym. 2011 ; 26 (4). 347-362
15. Zhang H, Chen Z. Fabrication and characterization of electrospun PLGA/MWNTs/hydroxyapatite biocomposite scaffolds for bone tissue engineering. J Bioact Compat Polym. 2010 ; 25 (3). 241-259
16. Volpato ZF, Lopes S, Ramos F, et al. Physical and in-vitro biological evaluation of a PA6/MWCNT electrospun composite for biomedical applications. J Bioact Compat Polym. 2011 ; 26 (1). 35-47
17. Toncheva A, Spasova M, Paneva D, et al. Drug-loaded electrospun polylactide bundles. J Bioact Compat Polym. 2011 ; 26 (2). 161-172
18. Ahrendt G, Chickering DE, Ranieri JP. Angiogenic growth factors: a review for tissue engineering. Tissue Eng. 1998 ; 4 (2). 117-130 (Pubitemid 28309075)
19. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003 ; 9 (6). 653-660 (Pubitemid 36749213)
20. Rahman N, Purpura KA, Wylie RG, et al. The use of vascular endothelial growth factor functionalized agarose to guide pluripotent stem cell aggregates toward blood progenitor cells. Biomaterials. 2010 ; 31 (32). 8262-8270
21. Hahn SK, Jelacic S, Maier RV, et al. Anti-inflammatory drug delivery from hyaluronic acid hydrogels. J Biomater Sci Polym Ed. 2004 ; 15 (9). 1111-1119 (Pubitemid 39317376)
22. Lee KW, Yoon JJ, Lee JH, et al. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan. Transplant Proc. 2004 ; 36 (8). 2464-2465 (Pubitemid 39550877)
23. Ho YC, Mi FL, Sung HW, et al. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. Int J Pharm. 2009 ; 376 (1-2). 69-75
24. Wissink MJ, Beernink R, Poot AA, et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release. 2000 ; 64 (1-3). 103-114 (Pubitemid 30035311)
25. Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 1986 ; 128 (3). 475-484 (Pubitemid 16015532)
26. Go DH, Joung YK, Lee SY, et al. Tetronic-oligolactide-heparin hydrogel as a multi-functional scaffold for tissue regeneration. Macromol Biosci. 2008 ; 8 (12). 1152-1160
27. Tan H, Gong Y, Lao L, et al. Gelatin/chitosan/hyaluronan ternary complex scaffold containing basic fibroblast growth factor for cartilage tissue engineering. J Mater Sci Mater Med. 2007 ; 18 (10). 1961-1968 (Pubitemid 47421889)
28. Patel S, Kurpinski K, Quigley R, et al. Bioactive nanofibers: synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett. 2007 ; 7 (7). 2122-2128 (Pubitemid 47197602)
29. Guarino V, Alvarez-Perez M, Cirillo V, et al. HMSC interaction with PCL and PCL/gelatin platforms: a comparative study on films and electrospun membranes. J Bioact Compat Polym. 2011 ; 26 (2). 144-160
30. Puppi D, Piras AM, Detta N, et al. Poly(vinyl alcohol)-based electrospun meshes as potential candidate scaffolds in regenerative medicine. J Bioact Compat Polym. 2011 ; 26 (1). 20-34
31. Miyazu K, Kawahara D, Ohtake H, et al. Luminal surface design of electrospun small-diameter graft aiming at in situ capture of endothelial progenitor cell. J Biomed Mater Res B Appl Biomater. 2010 ; 94 (1). 53-63
32. Lord MS, Yu W, Cheng B, et al. The modulation of platelet and endothelial cell adhesion to vascular graft materials by perlecan. Biomaterials. 2009 ; 30 (28). 4898-4906
33. Conte MS. The ideal small arterial substitute: a search for the Holy Grail?. FASEB J. 1998 ; 12 (1). 43-45
34. Maniglio D, Bonani W, Bortoluzzi G, et al. Electrodeposition of silk fibroin on metal substrates. J Bioact Compat Polym. 2010 ; 25 (5). 441-454
35. Yoshimoto H, Shin YM, Terai H, et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials. 2003 ; 24 (12). 2077-2082 (Pubitemid 36298779)
36. Ranjan AK, Kumar U, Hardikar AA, et al. Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis. PLoS One. 2009 ; 4 (11). e7718
37. Im GI, Lee JH. Repair of osteochondral defects with adipose stem cells and a dual growth factor-releasing scaffold in rabbits. J Biomed Mater Res B Appl Biomater. 2010 ; 92 (2). 552-560
38. Van Luyn MJ, Van Wachem PB, Damink LO, et al. Relations between in vitro cytotoxicity and crosslinked dermal sheep collagens. J Biomed Mater Res. 1992 ; 26 (8). 1091-1110
39. Jeon O, Song SJ, Kang SW, et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials. 2007 ; 28 (17). 2763-2771 (Pubitemid 46413347)
40. Stoilova O, Manolova N, Gabrovska K, et al. Electrospun polyacrylonitrile nanofibrous membranes tailored for acetylcholinesterase immobilization. J Bioact Compat Polym. 2010 ; 25 (1). 40-57
41. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials. 2010 ; 31 (24). 6279-6308
42. Parthasarathy AM, Isaac AR, Matthew JB, et al. Evaluation of biological activity of bone morphogenetic proteins on exposure to commonly used electrospinning solvents. J Bioact Compat Polym. 2011 ; 26 (6). 578-589
43. Wissink MJ, Beernink R, Pieper JS, et al. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials. 2001 ; 22 (16). 2291-2299 (Pubitemid 32591363)
44. Guan J, Stankus JJ, Wagner WR. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release. 2007 ; 120 (1-2). 70-78 (Pubitemid 46874620)
45. Sun B, Chen B, Zhao Y, et al. Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor. J Biomed Mater Res B Appl Biomater. 2009 ; 91 (1). 366-372
46. Nillesen ST, Geutjes PJ, Wismans R, et al. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials. 2007 ; 28 (6). 1123-1131 (Pubitemid 44809425)
47. Lv Q, Cao C, Zhu H. A novel solvent system for blending of polyurethane and heparin. Biomaterials. 2003 ; 24 (22). 3915-3919 (Pubitemid 36794397)
48. Singh S, Wu BM, Dunn JC. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials. 2011 ; 32 (8). 2059-2069
49. Kolmakova A, Rajesh M, Zang D, et al. VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. Glycoconj J. 2009 ; 26 (5). 547-558